Dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: safety, tolerability, and efficacy.

Drug Healthc Patient Saf · 2010 · PMC3108711 · PMID 21701614

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

71 Interestingly, upon meta-analysis, there was a nonsignificant trend toward a greater reduction of HbA 1c in trials enrolling patients with a mean baseline HbA 1c less than 8%. 51 A clear explanation for this discrepancy is not currently available.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.